ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,402.69
2.00%
S&P 500
5,060.40
0.84%
Dow Jones
38,200.28
0.78%
US Dollar vs Yen
153.3695
-1.51%
Brent Oil
83.845
0.37%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) ニュース

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ANIP
日付受信時刻ニュースソース見出しコード企業名
2024/05/0205 : 30GlobeNewswire Inc.ANI Pharmaceuticals to Participate at Two Upcoming Healthcare ConferencesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/1905 : 05GlobeNewswire Inc.ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0919 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Baclofen Oral SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0419 : 50GlobeNewswire Inc.ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with SarcoidosisNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0319 : 50GlobeNewswire Inc.ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma SymposiumNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/2719 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0909 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0907 : 59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0906 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0811 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0811 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0811 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0811 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0806 : 05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0707 : 58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0707 : 31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0706 : 29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0706 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0607 : 00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0509 : 18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0207 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0206 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0206 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/0206 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/02/2921 : 22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
FX
USDGBP
US Dollar vs Sterling
CCOM
US30
US 30
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
NYSE
AXP
American Express
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有